New imaging technology promises better breast cancer detection in early stages

June 24, 2002

Torrance, Calif. (June 24, 2002) - Scientists at the Research & Education Institute at Harbor-UCLA Medical Center (REI) are developing a new breast imaging diagnostic tool which will afford clinicians greater opportunities for detecting early stage breast cancers with greater certainty and help patients avoid biopsy in some cases. This detection method identifies breast lesions utilizing a radiopharmaceutical diagnostic imaging technology known as Tc-99 Sestamibi (MIBI) scintimammography. The procedure is based on a radioactive isotope being injected into a vein in the arm. Once absorbed into the body, the isotope can be seen by a group of special detectors, called gamma cameras, "marking" certain biological processes to locate a tumor.

Iraj Khalkhali, MD, principal investigator at REI, believes that the number of false negative (i.e., missed tumors) readings could be reduced if the limitations of contemporary gamma cameras were overcome. In one of his studies, Dr. Khalkhali found that three out of four false negatives were in the middle part of the breast and out of range of close camera contact. Dr. Khalkhali is currently pursuing research on improving scintimammography image quality through the design and development of a compact, thin gamma camera that affords easier access to all nodes and potential breast lesion sites.

"Access to breast lesions in the internal quadrants is especially important because these tumors may disseminate toward the internal mammary chain even when no axillary node is invaded. Easy access to all nodes and potential breast lesion sites will improve image quality and can be expected to improve the diagnostic accuracy of scintimammography, " said Dr. Khalkhali. "Although mammography is currently the standard early diagnostic screening tool, scintimammography has proven to be a highly effective adjunct in identifying lesions missed by mammography - particularly in women with dense breast tissue, low suspicion lesions on mammograms, pre-menstrual women with lumps in their breasts and women with locally advanced breast cancer," he added.
-end-
Dr. Khalkhali has long been recognized as an innovator and pioneer in advancing breast imaging techniques. He is founder and first president of the Nuclear Radiology Section of the Los Angeles Radiological Society. A graduate of the University of Tehran School of Medicine, he served his residency in diagnostic radiology at the Albert Einstein College of Medicine, Bronx, NY, and the University of California, Davis. He is the recipient of the County of Los Angeles Commendation for Excellence in Women's Health for 2001, winner of the Outstanding and First Place Resident Research Award 1997 for a paper presented on "Detection of Axillary Lymph Node Metastasis of Breast Carcinoma with Technetium 99m Sestamibi Scintimammography", and holds a patent for the scintigraphy guided stereotaxic localization technique of breast tumors.

The Research & Education Institute at Harbor-UCLA Medical Center, located on the campus of Harbor-UCLA Medical Center in Torrance, California, is a leading independent, not-for-profit biomedical research institute with an international reputation for scientific discovery, the training of physician-scientists and the provision of community service programs. It is an affiliate of both the David Geffen School of Medicine at UCLA and the Harbor-UCLA Medical Center and has an annual budget of $58 million. The Institute traces its roots back to 1952, when researchers and physicians joined forces with the UCLA School of Medicine on the campus of what was then known as Harbor General Hospital to conduct a handful of research studies. Today, more than 1,000 research projects and clinical trials are being conducted at REI, advancing scientific understanding in order to improve medical outcomes and promote innovation in such areas as autoimmune disorders, cancer, cardiovascular disease, developmental disorders and other pediatric health problems, diabetes, infectious disease, inherited disorders, male contraception, vaccine evaluation and research, and various aspects of women's health.

LA BioMed

Related Mammography Articles from Brightsurf:

AI tool improves breast cancer detection on mammography
Artificial intelligence (AI) can enhance the performance of radiologists in reading breast cancer screening mammograms, according to a new study.

Mammography screening saves lives also in older age
Mammography, which is an x-ray picture of the breast, is efficient also for women over the age of 70.

Six-month follow-up appropriate for BI-RADS 3 findings on mammography
Women with mammographically detected breast lesions that are probably benign should have follow-up surveillance imaging at six months due to the small but not insignificant risk that the lesions are malignant, according to a new study.

Tomosynthesis outperforms digital mammography in five-year study
A new study has found that the advantages of digital breast tomosynthesis (DBT) over digital mammography (DM), including increased cancer detection and fewer false positive findings, are maintained over multiple years and rounds of screening.

More women in US receive 3D mammography but disparities remain
Use of 3D mammography, an advanced form of breast cancer screening, has risen rapidly in recent years, according to Yale researchers in a new study.

Managing architectural distortion on mammography based on MR enhancement
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US) correlate or magnetic resonance imaging (MRI) enhancement suggests follow-up rather than biopsy may be safely performed, according to a study to be presented at the ARRS 2019 Annual Meeting, set for May 5-10 in Honolulu, Hawaii.

Older women benefit significantly when screened with 3D mammography
Mammography remains an effective method for breast cancer screening in women ages 65 and older, with the addition of a 3D technique called tomosynthesis improving screening performances even more, according to a new study.

3D mammography significantly reduces breast biopsy rates
The use of digital breast tomosynthesis, also known as 3D mammography, may significantly reduce the number of women who undergo breast biopsy for a non-cancerous lesion following an abnormal mammogram, according to a new study.

Digital mammography increases breast cancer detection
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United Kingdom without increasing the recall rate, according to a major new study.

New study supports mammography screening at 30 for some women
A new, large-scale study of more than 5 million mammograms found that annual mammography screening beginning at age 30 may benefit women with at least one of three specific risk factors: dense breasts, a personal history of breast cancer or a family history of breast cancer.

Read More: Mammography News and Mammography Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.